Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma.

Kathiravetpillai, N

Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma. [electronic resource] - European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Aug 2016 - 1183-90 p. digital

Publication Type: Journal Article

1532-2157

10.1016/j.ejso.2016.03.033 doi


Adenocarcinoma--pathology
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Chemoradiotherapy
Esophageal Neoplasms--pathology
Esophagectomy--methods
Female
Fluorouracil--administration & dosage
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Paclitaxel--administration & dosage
Postoperative Complications--epidemiology
Radiotherapy, Conformal
Retrospective Studies
Time Factors
Treatment Outcome